心臓代謝ストレス下におけるPVNにおけるレニン・アニオテンシンシステムの細胞および分子構造
Haifeng Zheng1,2, Ha Nguyen3, Khoi Nguyen3
1Department of Medicine, University of Rochester Medical Center, Rochester, NY, 14642, USA.
bioRxiv : the preprint server for biology
|September 2, 2025
まとめ
この研究では,レニン-アニオテンシン系 (RAS) の成分が脳のパラベントリキュラー核 (PVN) の内にある異なる細胞タイプで具体的に表現されていることが明らかになりました. 高血圧と肥満が 特定のPVNニューロンとアストロサイトにおける RASシグナル伝達に 影響を及ぼすことを示しています
科学分野:
- 神経科学
- 心血管生物学
- 代謝に関する研究
背景:
- 血圧と代謝の調節には極めて重要です.
- レニン- 血管新生系 (RAS) は高血圧と肥満に作用するが,PVNにおける細胞型特異的な機能は不明である.
研究 の 目的:
- PVNのRASコンポーネントのセルタイプ特有の表現をマッピングする.
- 高血圧と肥満がPVN内のRASシグナリングをどのように変化させるかを調査する.
主な方法:
- 単核RNAシーケンシング (snRNA-seq) を用いて,雄性マウスのPVN細胞をプロファイルした.
- ネズミは,DOCA塩による高血圧および高脂肪食 (HFD) による肥満を研究した.
主要な成果:
- 主要なPVN細胞タイプと8つのニューロンのサブタイプを特定した.
- RAS遺伝子の発現は細胞タイプに特異的であり,アニオテンシンゲン (Agt) はアストロサイトで,他のものは神経細胞で (Ace, Atp6ap2, Agtr1a, Lnpep, Mas1) 発現した.
- DOCA塩の治療はGABAergicおよびバソプレシンニューロンを変化させ,ニューロンのAgtとAtp6ap2を増加させ,同時にアストロサイト Agtを減少させた.
- HFDは刺激性/ストレスニューロンを増加させ,バソプレシンニューロンにおける特定のRAS遺伝子を上昇させ,GABAergicニューロンにおけるRAS遺伝子を低下させました.
結論:
- 高血圧および代謝的ストレスに反応して,PVN RASシグナリングのダイナミックな,細胞型特異的な改造が起こります.
- PVN RAS表現のトランスクリプトミックのアトラスを提供します.
- 心臓代謝障害の治療のための潜在的な細胞標的を特定します.
関連する概念動画
Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Neural Regulation of Blood Pressure
3.4K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.4K
Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Hormonal Regulation of Blood Pressure
3.1K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.1K


